News

Filter

Current filters:

Transderm Scop

FDA rejects Nastech's New Drug Application for motion sickness drug

24-02-2000

Nasal delivery specialist Nastech has been informed by the US Food andDrug Administration that the agency…

Isopto HyoscineScopolamineTransderm Scop

Nastech files NDA for intranasal scopolamine

21-12-1999

Nastech has filed a New Drug Application with the US Food and DrugAdministration, seeking approval to…

ApokynApomorphineIsopto HyoscineScopolamineTransderm Scop

Nastech to file NDA for motion sickness drug

12-07-1999

Nastech Pharmaceutical has said that following positive Phase III datafrom trials of intranasal scopolamine…

Isopto HyoscineScopolamineTransderm Scop

Novartis To Relaunch Scopolamine Patches

13-11-1997

- Novartis has reintroduced its Transderm Scop scopolaminebehind-the-ear patch for motion sickness.…

Isopto HyoscineNovartisScopolamineTransderm Scop

Noven Files Two INDs

16-10-1997

- Noven Pharmaceuticals has filed two Investigational New Drugapplications with the US Food and Drug…

Isopto HyoscineKetoprofenOrudisScopolamineTestosteroneTransderm Scoptransdermal

Cognitive Enhancers Unveiled At ASM

21-11-1994

Details of two new cognition-enhancing drugs have been presented at the annual meeting of the American…

CognexDopamineDopamine HydrochlorideIsopto HyoscineScopolamineTacrineTransderm Scop

COMPANY SPOTLIGHT

Menarini

Back to top